T-cell recognition of cancer epitopes lies at the heart of effective cancer immunotherapy. This symposium will bring together leading experts to discuss the latest advances in cancer T-cell recognition, spanning fundamental mechanisms of antigen presentation and T-cell receptor (TCR) recognition to cutting-edge clinical applications, including TCR-engineered T-cell therapies, cancer vaccine development, and allo-recognition of cancer cells.

Each session will feature internationally recognized keynote speakers alongside selected short talks selected from submitted abstracts, providing a dynamic forum for scientific exchange. Join us in Lausanne, a thriving hub for cancer immunotherapy research at the heart of Europe.

Date: March 10 and 11, 2027, 08:30–17:30
Location: Paternot Auditorium – AGORA – Rue du Bugnon 25A, Lausanne, Switzerland

Registration information: Registration
(early bird registration and abstract submission deadline: January 15, 2027; final registration deadline: February 15, 2027).

We are happy to announce that 3 fellowships are available to cover the travel and accommodation from participants coming from abroad. More information on the Registration page.

We look forward to welcoming you.